aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
November 13, 2023 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its...
aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
November 09, 2023 16:00 ET
|
aTyr Pharma, Inc.
Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected to complete enrollment early in the second quarter of 2024. Phase 2 EFZO-CONNECT™ study of efzofitimod in SSc-ILD initiated...
Access Recognized for Second Consecutive Year in Inc.’s Annual Power Partner Awards
October 25, 2023 09:00 ET
|
Access Information Management Shared Services, LLC
Roundup highlights B2B partners that support startups across all business functions and empower growth for their clients.
Intetics Is Recognized as Inc. 2023 Power Partner Awards Honoree in the AI & Data Category
October 25, 2023 06:01 ET
|
Intetics Inc.
Inc. named Intetics an honoree on the 2023 Power Partner Awards list in the Artificial Intelligence & Data category.
MarginEdge Recognized by Inc.’s Power Partner Awards and Washington Business Journal’s Fastest Growing Companies 2023
October 24, 2023 08:00 ET
|
MarginEdge
ARLINGTON, Va., Oct. 24, 2023 (GLOBE NEWSWIRE) -- MarginEdge, the leading restaurant management and bill payment platform, today announced it has been recognized by the 2023 Inc. Power Partners...
Text Request Honored with Inc. Power Partner Award for 2nd Year
October 24, 2023 07:33 ET
|
Text Request
CHATTANOOGA, TENN., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Text Request, the industry-leading business messaging platform, has been recognized as an Inc. Power Partner for the second year in a row....
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
September 11, 2023 08:00 ET
|
aTyr Pharma, Inc.
Post-hoc analysis from Phase 1b/2a study in pulmonary sarcoidosis presented at the European Respiratory Society (ERS) International Congress 2023. 7.7% of patients in the 3.0 and 5.0 mg/kg...
Barrack, Rodos & Bacine Investigates Napco Security Technologies, Inc. (NSSC)
August 24, 2023 09:30 ET
|
Barrack Rodos & Bacine
PHILADELPHIA, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Barrack, Rodos & Bacine (BR&B) is investigating Napco Security Technologies, Inc. (“Napco”) (NASDAQ: NSSC) for potential violations of federal...
Leadership Aroostook’s Second Graduating Class Creates Operational Plans to Move the County Forward
July 14, 2023 08:05 ET
|
Husson University
BANGOR, MAINE, July 14, 2023 (GLOBE NEWSWIRE) -- Fourteen professionals from 10 different prominent County businesses recently completed Leadership Aroostook, a professional development initiative...
Annonce de l’octroi de fonds à l’Intention des collèges, de façon à renforcer les collaborations clés entre les collectivités et le milieu de la recherche
May 24, 2023 10:39 ET
|
Fondation canadienne pour l’innovation
OTTAWA, 24 mai 2023 (GLOBE NEWSWIRE) -- Les capacités en matière d’innovation du Canada reposent essentiellement sur des travaux de recherche appliquée que les collèges de tout le pays mènent. Que...